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In recognition of
the complex mix of
motives that has
led to an increased
use of imaging mo-
dalities, the medical
community has
taken on the re-
sponsibility of iden-
tifying gaps in care
and providing so-
lutions focused on
ensuring quality
and appropriate use
of technologies. To-
day, the ACC is
widely credited by
payers, members of
Congress, and other
stakeholders for
working to address
a perceived problem
and taking proac-
tive efforts to en-
sure quality, cost-
effective care.The New England Journal of Medicine has called medical imaging one of the“great medical developments of the past thousand years” (1)—and even in thelast 10 to 15 years, we have seen technological advances that have completely
hanged the way we deliver patient care on a daily basis. For cardiology in particular,
oninvasive imaging is now central to clinical practice and research, irrespective of the
isease entity or the area of interest of the cardiologist.
The cardiac care team now has a wide range of noninvasive imaging techniques that
nable them to provide earlier and more accurate diagnosis and better quality care.
chocardiography, nuclear imaging, cardiac computed tomography (CCT), and cardiac
agnetic resonance (CMR) enable us to image the beating heart and its structures in
hree dimensions; evaluate cardiac function, valvular disease,and the anatomy and physi-
logy of the coronary arteries; and even detect the early stages of atherosclerosis. In
hort, noninvasive techniques allow us to more clearly see various aspects of disease that
sed to remain obscure even with riskier, costlier, more invasive procedures. From early
etection of disease to guidance of therapies in hybrid operating suites, imaging is now
biquitous and essential.
Imaging Utilization: Trends and Threats
Despite the benefits of medical imaging, it is not without cost. Policymakers at the state
and national level, as well as private payers, have expressed concern over the years about
the rising volume of imaging because of the increase in healthcare costs associated with
this growth. Their response has been to seek control over who can perform imaging
tests and where, through administrative protocols or state and federal laws.
The largest federal effort to regulate office-based medical imaging occurred as part of
the Deficit Reduction Act of 2005 (DRA). This law cut payments for many office-based
imaging services by requiring that payment for the technical component of an imaging
service be charged at either the hospital outpatient prospective payment system
(HOPPS) rate or the physician fee schedule amount, whichever is lower. Other cuts to
imaging payments stem from drastic revisions to the practice expense methodology and
changes with the ongoing review of “potentially misvalued” services in the Resource-
Based Relative Value Scale. Today, further reductions in imaging reimbursements are
being considered as a possible way to offset other Medicare payments. The significant
reduction in reimbursement of cardiovascular imaging that has occurred in the past 5
years is in large part behind the observed migration of cardiologists from private practice
to employment by hospitals and health care systems.
On the payer front, some of the nation’s largest insurers have contracted with radiol-
ogy benefit managers (RBMs) to limit the growth of imaging. Under the RBM model,
providers must get prior authorization to perform an imaging test in order to be reim-
bursed. A June 2008 General Accounting Office (GAO) report recommended that the
Centers for Medicare and Medicaid Services (CMS) examine the feasibility of this ap-
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the short term but it unquestionably burdens the time and
resources of the care team, payers, and the healthcare sys-
tem. Furthermore, experience suggests that measures
aimed at limiting costs through administrative oversight
too often end up denying care to patients who really need
it, and not reducing costs in the long run as much as
shifting money away from the providers of care.
States have also been a battleground on imaging issues.
Lawmakers and other interest groups have pushed legisla-
tion to completely ban in-office imaging or place arbitrary
limits on reimbursement for nonradiologists. In July 2008,
the American College of Cardiology (ACC) Arizona
Chapter played an instrumental role in defeating a bill
(S.B. 1224) that would have frozen in-office medical im-
aging for nuclear medicine and certain advanced imaging
modalities at 2008 levels. In all states, the threat of legis-
lation that limits access to in-office imaging remains and
the College, working with local chapters, continues efforts to
educate lawmakers on the benefits of in-office medical imag-
ing, including the timeliness of diagnosis and treatment,
convenience to patients, efficiency, and cost-effectiveness of
care.
Quality Versus Quantity:
The Importance of Appropriate Use Criteria
In truth, many factors have led to a greater reliance on
imaging besides their ability to provide clinicians more
accurate and detailed information about physiological
conditions. Changing patient demographics (metabolic
syndrome, aging, atrial fibrillation, and so on) have argu-
ably increased the need for the kinds of information read-
ily provided by imaging. Greater patient awareness also
contributes to the demand for imaging technologies, be-
cause some patients want state-of-the-art care, while oth-
ers want the certainty that seems to be promised by tech-
nology. The fragmentation of care contributes to repeated
tests when previous studies are unavailable; the threat of
lawsuits leads many physicians to practice, consciously or
subconsciously, defensive medicine and rely on technolo-
gies as an objective means to ground decisions that inevi-
tably require fine judgment; the demise of the physical
examination and its replacement by an imaging test is also
a factor for the specialist and generalist. Unfortunately,
we must also face the fact that the greater availability of
these technologies combined with fee-for-service incen-
tives can sway physicians toward greater reliance on imag-
ing than if the tests were still difficult, invasive, and
costly.
In recognition of the complex mix of motives that has
led to an increased use of imaging modalities, the medicalcommunity has taken on the responsibility of identifying
gaps in care and providing solutions focused on ensuring
quality and appropriate use of technologies. Today, the
ACC is widely credited by payers, members of Congress,
and other stakeholders for working to address a perceived
problem and taking proactive efforts to ensure quality,
cost-effective care.
The development of appropriate use criteria (AUC) is
one of the cardiovascular community’s most significant
contributions. AUC define when and how often it is rea-
sonable to perform a given procedure or test. When sys-
tematically implemented, AUC can be used to assess pat-
terns of care in an effort to understand and improve the
rate of clinically appropriate imaging tests, while reducing
clinically less appropriate tests. By providing physicians
their imaging utilization, AUCs also engage the providers
in shared responsibility for judicious use of imaging ser-
vices and can effect appropriate change in behavior better
than that observed with changing reimbursement.
The first AUC document for single-photon emission
computed tomography myocardial perfusion imaging
(SPECT MPI) was released in October 2005. Since then
the College has continued to refine the process by intro-
ducing an early review of proposed clinical scenarios, us-
ing larger expert panels, basing AUC on more compre-
hensive lists of clinical scenarios, and improving ongoing
coordination with clinical guidelines and other ACC pol-
icy documents. To date, the ACC Foundation has devel-
oped, in collaboration with subspecialty societies, AUCs
for echocardiography, cardiac radionuclide imaging, CCT,
CMR, and peripheral arterial and venous ultrasound
among others. Currently under development in the realm
of imaging are documents on ultrasound use in pediatric
patients and multi-modality imaging use in heart failure,
chest pain, and stable ischemic heart disease.
The good news is that medical imaging growth has
declined since 2006. A recent report by the Medical Im-
aging and Technology Alliance for MedPAC (3) found
that:
• spending on imaging services per Medicare benefi-
ciary has declined by 16.7 % since 2006, while
spending on nonimaging services has increased by
21.3% over the same period.
• per-beneficiary use of imaging services has declined
by 5.1% since 2009, while use of advanced imaging
services has decreased 6.6 %.
• total spending on imaging services represents a
smaller share of overall Medicare spending (9.3%)
than at any point in the past decade and has shrunk
by 28.4% since 2006.
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all medical imaging, with slowing of imaging utilization
even prior to 2005 (Fig. 1). Advanced new imaging mo-
dalities (CCT and CMR) continue to constitute a small
fraction (0.1% to 1%) of conventional echocardiography
and nuclear imaging. Factors that contributed to the de-
crease in utilization and slowing of the growth of medical
imaging include the DRA, more awareness of cost and
utilization, RBMs, AUC by professional societies (partic-
ularly ACC and ACR), and more recent evidence incor-
porated into AUCs on the need for fewer serial studies in
stable patients (4).
Enhancing the Quality and Safety of Imaging
Accreditation of laboratories is another important contrib-
utor to improvements in quality and appropriate use of
imaging. As of January 2012, under the Medicare Im-
provements for Patients and Providers Act of 2008
(MIPPA), providers of the technical component for ad-
vanced diagnostic imaging services (nuclear, CT, and
CMR) must be accredited by a designated accreditation
organization. Facilities are evaluated based on criteria that
include standards for qualifications of medical personnel
who furnish the technical component; qualifications and
responsibilities of medical directors and supervising physi-
cians; procedures to ensure that the equipment used meets
performance specifications; standards that require the sup-
pliers have procedures in place to ensure the safety of
both advanced diagnostic imaging providers and patients;
and, lastly, standards that require the establishment and
Figure 1 Percent Change in CV Imaging
Percent change from year to year in utilization of cardiovascular (CV) imaging
procedures in all Medicare fee-for-service, at all sites. (Procedures during
2011: Echo  7.11 million; nuclear 2.46 million; CCT  50,000, CMR 
15,000). Data represent global and professional service billing for services in
Medicare fee-for-service at all sites of service (inpatient hospital, physician
office, etc.). Percent change calculation divides utilization of one year by the
previous year. Percent changes to cardiac magnetic resonance (CMR) are
highly sensitive due to low utilization. Percent changes to cardiac computed
tomography (CCT) are highly sensitive due to low utilization. SPECT MPI  single-
photon emission computed tomography myocardial perfusion imaging. Data
provided by ACC staff, James Vavricek.maintenance of a quality assurance and quality control
program.
The ACC was a strong proponent of the MIPPA pro-
vision, believing that accreditation provides an indepen-
dent evaluation and validation of imaging facilities that
allows laboratories to be held to a level of accountability
and quality for the patient care they provide. It also can
help reduce inappropriate imaging as the Inter-Societal
Accreditation Commission has incorporated AUCs in
their evaluation criteria.
In recent years, the ACC initiated the national “Imag-
ing in FOCUS” (FOCUS), a self-directed, quality im-
provement software and interactive community, to help
providers better understand their imaging practices, iden-
tify areas for improvement, and incorporate AUC at the
point of care. It has proven successful in reducing overuse
of imaging. Unlike RBMs, which have been criticized by
health care providers for delaying or denying necessary
imaging studies, creating unsustainable administrative
burdens, basing decisions on inconsistent rules and prac-
tices, and lacking clinical guideline transparency, FOCUS
is transparent, grounded in AUC, and provides opportu-
nities (and in some cases incentives) for improved AUC
adherence.
Preliminary data from the FOCUS group showed that
with the use of such an approach, physicians in 30 differ-
ent practices were able to decrease significantly the pro-
portion of SPECT MPI tests not meeting appropriate
use, from 11% to 5% in a cohort of more than 1000 stud-
ies (5). A recent study of 472 patients with suspected cor-
onary artery disease found that the use of a real-time,
multimodality decision-support tool, like the one used in
FOCUS, led to a reduction in inappropriate testing from
22% in the first 2-month period to 6% in the last 2
months (6). Similarly, a significant impact of a continuous
quality improvement initiative was seen on the utilization
of coronary CT angiography (7).
As a result of these successes, the College is working to
expand FOCUS beyond health plans and the current
case-review tool to offer an ongoing subscription service
directly to hospitals and practices that would integrate
AUC decision support directly into electronic health re-
cords for all noninvasive cardiac imaging. The subscrip-
tion service will allow practices to track AUC on a con-
tinual basis and then use the information as part of a
quality improvement module that will offer MOC Part IV
credit and meet laboratory accreditation quality review
standards. There are potential opportunities to help eligi-
ble providers meet Physician Quality Reporting System
(PQRS) requirements. There is also growing interest on
the part of health plans and practices in incorporating
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countable care organizations (ACOs) and episode or global-
based payment models.
A Look Into the Future
There is no doubt that imaging modalities will only con-
tinue to improve technologically and enhance our ability
to diagnose and treat patients earlier in the course of a
disease. While we continue to develop many genetic
markers of disease in addition to other measurable risk
factors, imaging provides the actual phenotype, which can
conceivably be detected at an even earlier stage with mo-
lecular imaging. On the other hand, scientists are busy
trying to develop low-radiation tracers and new CT tech-
niques to address safety concerns and reduce radiation
exposure.
With advancement in digital technology and miniatur-
ization, imaging will run the gamut from high-end large
equipment to handheld imaging devices. The latter will
proliferate for bedside diagnosis with ultrasound and
other technology; the smaller, more compact designs will
not only be less expensive to produce, but allow more
physicians to take advantage of technology and use it at
the point of care. Healthcare payment models will likely
encourage their utilization for greater efficiency. The po-
tential opportunities for international distribution to de-
veloping countries are great.
With a more cost-conscious and value-driven healthcare
system, there is a new imperative for medical imaging.
Novel technologies need ultimately to show a positive
effect on patient care and outcome. With the availability
of many modalities for imaging, there is confusion as to
their best utilization. Rather than risk arbitrary cuts im-
posed by administrative processes far removed from the
needs of the patient, we as physicians need to continue
taking the lead in comparative research to assess the mosteffective uses of imaging to diagnose and manage com-
mon cardiovascular disease. This would also reduce the
layering of multiple modalities, for considerations of both
safety and cost. Ultimately, our driving concern is to
achieve the triple aim of quality care, reasonable cost, and
the health of the population.
Medical imaging is integral to the practice of cardio-
vascular care. I’m proud of the College and its members
for being at the forefront of this continuously developing
field and working to make sure that patients reap the
benefits of advances in imaging technology in a transpar-
ent, evidence-based manner.
Address correspondence to:
William A. Zoghbi, MD, FACC
American College of Cardiology
2400 N Street NW
Washington, DC 20037
E-mail: president@acc.org
REFERENCES
1. Looking Back on the Millennium in Medicine. N Engl J Med
2000;342:42–9.
2. A New Era of Responsibility: Renewing America’s Promise. U.S. Government
Printing Office, 2009. Available at: http://www.elsevierbi.com//media/
5A17550FD74343F191680BB07E075534. Accessed October 24, 2012.
3. Imaging Today: Medical Imaging Trends in Medicare; September 20, 2012.
Available at: http://www.medicalimaging.org/wp-content/uploads/2012/09/
Medicare-2011-Data-MITA-Report-Final-9.20.2012.pdf. Accessed October
24, 2012.
4. Lewin DC, Rao VM, Parker L. Physicians orders contribute to
high-tech imaging slowdown. Health Affairs 2010;29:189–95.
5. Allen JM. A national initiative to improve utilization of cardiac imaging:
the FOCUS learning community and performance improvement module
(abstr). Circ Cardiovasc Qual Outcome 2011; 4 Suppl:231.
6. ACC-based software boosts appropriateness of heart scans. July, 23, 2012.
Available at: http://www.auntminnie.com/redirect/redirect.asp?
itemid100015. Accessed October 24, 2012.
. Chinnaiyan KM, Peyser P, Goraya T, et al. Impact of a continuous
quality improvement initiative on appropriate use of coronary computed
tomography angiography. J Am Coll Cardiol 2012;60:1185–91.
